Compare TCI & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCI | EBS |
|---|---|---|
| Founded | 1983 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 343.6M | 409.5M |
| IPO Year | 1994 | 2006 |
| Metric | TCI | EBS |
|---|---|---|
| Price | $35.43 | $8.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 3.1K | ★ 726.1K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 135.29 | 125.83 |
| EPS | ★ 1.60 | 0.93 |
| Revenue | $49,060,000.00 | ★ $742,900,000.00 |
| Revenue This Year | N/A | $1.29 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $22.10 | ★ $8.85 |
| Revenue Growth | ★ 4.23 | N/A |
| 52 Week Low | $26.96 | $4.02 |
| 52 Week High | $59.65 | $14.06 |
| Indicator | TCI | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 45.48 | 39.85 |
| Support Level | $31.48 | $7.83 |
| Resistance Level | $47.17 | $9.28 |
| Average True Range (ATR) | 1.54 | 0.27 |
| MACD | 0.65 | 0.13 |
| Stochastic Oscillator | 50.11 | 44.93 |
Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.